Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00167245 · ClinicalTrials.gov registry record · Phase 2

Topiramate for Alcohol and Cocaine Dependence

A Phase 2 study of Alcoholism and Cocaine Dependence, sponsored by Kyle Kampman.

Completed
Registry status
Phase 2
Development phase
170
Enrollment target
1
Study location

NCT00167245 is a Phase 2 study of Alcoholism and Cocaine Dependence that has completed, run by Kyle Kampman. The registered enrollment target is 170 participants, below the 372-participant average among 65 other Alcoholism trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00167245, a Phase 2 study of Alcoholism and Cocaine Dependence, has completed, sponsored by Kyle Kampman.

COMPLETED
Registry status
Phase 2
Development phase
170 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to test the effectiveness of topiramate for the treatment of combined alcohol and cocaine dependence. Topiramate is approved for the treatment of seizures. It has not been proven to be effective for the treatment of alcohol or cocaine dependence.

Conditions Studied

Alcoholism Cocaine Dependence

Interventions

  • DRUG placebo
  • DRUG Topiramate

Study Locations (1)

Pennsylvania

  • University of Pennsylvania, Treatment Research Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2004-09
Est. Completion 2010-06
Phase Phase 2

Sponsor

Kyle Kampman

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00167245

The ClinicalTrials.gov registry entry for NCT00167245 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 372-participant average among 65 other Alcoholism trials with a reported enrollment target (54% lower). The listed sponsor is Kyle Kampman, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00167245 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00167245 about?

NCT00167245 is a clinical study titled "Topiramate for Alcohol and Cocaine Dependence". The primary purpose of this study is to test the effectiveness of topiramate for the treatment of combined alcohol and cocaine dependence. Topiramate is approved for the treatment of seizures. It has not been proven to be effective for the treatment of alcohol or cocaine dependence.

What is the current status of trial NCT00167245?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2004-09. Estimated completion is 2010-06.

What conditions does trial NCT00167245 study?

This clinical trial studies the following conditions: Alcoholism, Cocaine Dependence.

What interventions are being tested in trial NCT00167245?

The interventions under investigation include: placebo (DRUG), Topiramate (DRUG).

Who is sponsoring clinical trial NCT00167245?

This trial is sponsored by Kyle Kampman, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00167245 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcoholism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcoholism

All registered trials for this condition

Cocaine Dependence

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.